2020

November 12, 2020
Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum

July 24, 2020
Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research

2019

March 13, 2019
Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers

2018

December 12, 2018
Tvardi Therapeutics names Imran Alibhai Chief Executive Officer

October 01, 2018
Tvardi’s Scientific Advisory Board Member, Dr. Jim Allison, Wins Nobel

September 20, 2018
Tvardi Announces Series A Financing